Apple's (AAPL) Healthcare Healthcare Opportunity Should Not Be Under Estimated - Morgan Stanley
Tweet Send to a Friend
Morgan Stanley analyst Katy Huberty reiterated an Overweight rating and $220.00 price target on Apple (NASDAQ: AAPL) noting that the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
